Maitrayee Goswami
Overview
Explore the profile of Maitrayee Goswami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Zheng G, Xu L, Goswami M, Zafereo M, Sherman S, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 Nov;
151(2):113-120.
PMID: 39602114
Importance: Genome-wide association studies have identified germline variants associated with the development of papillary thyroid carcinoma (PTC) that can be used to construct a polygenic score (PGS). It is important...
2.
Chen Y, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, et al.
Thyroid
. 2022 Dec;
33(3):321-329.
PMID: 36511380
A history of thyroid and nonthyroid malignancies has traditionally been an exclusion criterion in patients with anaplastic thyroid cancer (ATC) seeking to enroll in clinical trials. In this study, we...
3.
Wang J, Montierth M, Xu L, Goswami M, Zhao X, Cote G, et al.
JCO Precis Oncol
. 2022 Aug;
6:e2100504.
PMID: 35977347
Purpose: Anaplastic thyroid carcinoma (ATC) uniformly present with aggressive disease, but the mutational landscape of tumors varies. We aimed to determine whether tumor mutations affect survival outcomes in ATC. Materials...
4.
Chen Z, Wang S, Goswami M, Tang G, Routbort M, Patel K, et al.
Leuk Res
. 2019 Sep;
86:106227.
PMID: 31557598
Presence of RS is closely associated with SF3B1 mutation in de novo MDS. RS is also present in a subset of therapy-related MDS (t-MDS), but data is not available in...
5.
Chen Z, Ok C, Wang W, Goswami M, Tang G, Routbort M, et al.
Cytometry B Clin Cytom
. 2019 Jun;
98(1):36-42.
PMID: 31211490
B-cell progenitors (hematogones) are markedly decreased or completely absent in the bone marrows of myelodysplastic syndromes (MDS), and the finding is considered as an important feature in MDS flow cytometry...
6.
Hu Z, Boddu P, Loghavi S, Miranda R, Goswami M, Medeiros L, et al.
Am J Hematol
. 2018 Aug;
93(11):1337-1346.
PMID: 30105844
The work-up of patients with hypereosinophilia (HE) is complex. Following the recently revised World Health Organization criteria, we retrospectively reviewed 125 patients who were referred to us to exclude a...
7.
Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, et al.
Mod Pathol
. 2018 Feb;
31(6):873-880.
PMID: 29403082
The 2016 WHO update changed the diagnostic criteria for myeloid neoplasms with erythroid predominance, limiting the diagnosis of acute myeloid leukemia to cases with ≥20% blasts in the bone marrow...
8.
Li F, Sutherland M, Yu C, Walter R, Westendorf L, Valliere-Douglass J, et al.
Mol Cancer Ther
. 2017 Nov;
17(2):554-564.
PMID: 29142066
Treatment choices for acute myelogenous leukemia (AML) patients resistant to conventional chemotherapies are limited and novel therapeutic agents are needed. IL3 receptor alpha (IL3Rα, or CD123) is expressed on the...
9.
Hu Z, Sun Y, Schlette E, Tang G, Li S, Xu J, et al.
Mod Pathol
. 2017 Oct;
31(2):327-336.
PMID: 28984300
CD200, a marker currently utilized in the diagnosis of B-cell lymphoma, is uniformly positive in chronic lymphocytic leukemia/chronic lymphocytic leukemia, and is usually absent in mantle cell lymphoma. Over a...
10.
Konoplev S, Lu X, Konopleva M, Jain N, Ouyang J, Goswami M, et al.
Am J Clin Pathol
. 2017 Mar;
147(4):357-363.
PMID: 28340183
Objectives: Cytokine receptor-like factor 2 ( CRLF2 ) rearrangement is found in approximately 50% of pediatric Ph-like B-cell acute lymphoblastic leukemia (B-ALL), and around 50% of CRLF2 + cases harbor...